U.S. Markets open in 6 hrs 6 mins
  • S&P Futures

    4,220.50
    +10.75 (+0.26%)
     
  • Dow Futures

    33,384.00
    +80.00 (+0.24%)
     
  • Nasdaq Futures

    13,347.50
    +36.25 (+0.27%)
     
  • Russell 2000 Futures

    1,983.00
    +6.70 (+0.34%)
     
  • Crude Oil

    94.27
    -0.07 (-0.07%)
     
  • Gold

    1,809.40
    +2.20 (+0.12%)
     
  • Silver

    20.40
    +0.05 (+0.23%)
     
  • EUR/USD

    1.0309
    -0.0016 (-0.1546%)
     
  • 10-Yr Bond

    2.8880
    0.0000 (0.00%)
     
  • Vix

    20.20
    +0.46 (+2.33%)
     
  • GBP/USD

    1.2197
    -0.0006 (-0.0476%)
     
  • USD/JPY

    133.2610
    +0.2620 (+0.1970%)
     
  • BTC-USD

    23,945.43
    -639.98 (-2.60%)
     
  • CMC Crypto 200

    568.75
    -5.99 (-1.04%)
     
  • FTSE 100

    7,488.17
    +22.26 (+0.30%)
     
  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

IBD 50 Stocks To Watch: Is This Drug Company's Stock A Buy?

·3 min read
IBD 50 Stocks To Watch: Is This Drug Company's Stock A Buy?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

One of several medical stocks on the IBD 50 list of growth stocks, drug giant AstraZeneca is trying to break out of a new base as the stock market struggles to remain in a confirmed uptrend. The U.K.- based maker of a wide variety of treatments is forming a double-bottom base, according to MarketSmith chart analysis. Its drugs include a Covid vaccine and cancer drugs Tagrisso, Imfinzi and Lynparza.